ArcherDX is now Invitae, bringing the future of precision oncology to cancer care. The transaction was completed in October 2020. Learn more here
Precision oncology
in your lab
ArcherDX is now Invitae. The combination was completed in October 2020 to bring comprehensive cancer genetics and precision oncology to patients worldwide.
The global fight against cancer requires advanced molecular detection products that are accurate, actionable, easy-to-use and available worldwide.
We provide a powerful product development platform for research that enables all molecular laboratories to solve complex genomic problems.
Our ultimate goal is to break down barriers to sophisticated genomic analysis in community and regional settings with our in vitro diagnostic (IVD) products that are currently in development.
